OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-04-30-accounts

REGISTERED COMPANY NUMBER: 02854091 (England and Wales) REGISTERED CHARITY NUMBER: 1029318

REPORT OF THE TRUSTEES AND AUDITED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2023

FOR

TAMESIDE & GLOSSOP HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

Moss & Williamson Limited Chartered Accountants Statutory Auditor Booth Street Chambers Ashton-under-Lyne Lancashire OL6 7LQ

TAMESIDE & GLOSSOP HOSPICE LIMITED

CONTENTS OF THE FINANCIAL STATEMENTS for the Year Ended 30 April 2023

Page
Report of the Trustees 1 to 14
Report of the Independent Auditors 15 to 17
Consolidated Statement of Financial Activities 18
Consolidated Balance Sheet 19
Company Balance Sheet 20
Cash Flow Statement 21
Notes to the Cash Flow Statement 22
Notes to the Financial Statements 23 to 39
Detailed Statement of Financial Activities 40 to 42

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

The trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 30 April 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

REFERENCE AND ADMINISTRATIVE INFORMATION

GOVERNING INSTRUMENT

Memorandum and Articles of Association (Company limited by guarantee)

REGISTERED COMPANY NUMBER

02854091 (England and Wales)

REGISTERED CHARITY NUMBER

1029318

PATRONS

Tony Husband (Deceased October 23) Justin Moorhouse Martin Wilde Julie Hesmondhalgh Sharman Birtles MBE Philip Cowper Julie Goodyear MBE Brian Wild

PRESIDENT

Martin J. Willescroft

PRINCIPAL OFFICERS

Chair: Vice Chairman: Chief Executive: Director of Clinical Services/Registered Manager: Head of Finance: Head of Income Generation

Philip Millson Mark Llewellin Karen Houlston MA Nicola Cheetham Ian Wicks FCCA Samantha Duncan

Executive Team (Non-Director/Trustees)

Karen Houlston MA Nicola Cheetham Ian D Wicks FCCA Samantha Duncan

Page 1

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

COUNCIL

Incorporating Director/Trustees

Martin J. Willescroft John H. Maltby LLB Stephen Flanagan Elizabeth Needham Philip J Millson Timothy Jackson Mark Llewellin Paul Schofield Joanne Ormston Rachel Freeman Resigned 18 December 2023

PRINCIPAL ADDRESS & REGISTERED OFFICE

Willow Wood Close Off Mellor Road Ashton-under-Lyne Lancashire OL6 6SL

AUDITORS

Moss & Williamson Limited Booth Street Chambers 32, Booth Street Ashton-under-Lyne Lancashire OL6 7LQ

SOLICITORS

Thompson & Cooke 12 Stamford Street Stalybridge Cheshire SK15 1LA

PRINCIPAL BANKERS & INVESTMENT MANAGERS

Investec Wealth & Investment Ltd NatWest Bank PLC 2[nd] Floor, 3 Hardman Street Warrington Street Spinningfields Ashton-Under-Lyne Manchester Lancashire M3 3HF OL6 6JL

Page 2

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

We are pleased to present our report and the audited financial statements of the company Tameside & Glossop Hospice Limited (known throughout the region as Willow Wood Hospice) for the year ended 30 April 2023.

Willow Wood Hospice is an independent, charitable voluntary body, funded in the main by the generosity of our local community of Tameside & Glossop.

Willow Wood opened its doors in 1999 and will be celebrating 25 years in 2024. The Hospice places great value on its connections and working relationships with our Integrated Care Board (ICB), local NHS foundation trust, local Council and local businesses.

Our driving force is that a Hospice is not just a building but a whole philosophy incorporating care, love and understanding for patients and their carers. This enables the patient to achieve the best quality of life appropriate to their individual needs and wishes throughout the changing phases of their illness, whilst acknowledging and responding to the needs of the families and carers. We aim to provide high quality care ensuring comfort and personal dignity at all times.

Our Aims & Objectives

We aim to continue to be a leader in the development of Hospice and Palliative care, providing excellence in quality care to the people of Tameside & Glossop.

Our Mission

To continue to provide, free of charge, the highest quality supportive and end of life care to patients with life limiting illnesses, along with love, care and support to the families and carers during illness and continuing after bereavement.

Our Values

Love and Care – for patients, families and carers Respect – for people in life and at the end of life Integrity – being open and honest Collaboration – by people working together Development – by sharing knowledge and skills for the benefit of all

Our Philosophy

A Hospice is not just a building but a whole philosophy incorporating care, love and understanding for patients and their carers. This enables the patient to achieve the best quality of life appropriate to their individual needs and wishes throughout the changing phases of their illness, whilst acknowledging and responding to the needs of the families and carers. We aim to provide high quality care ensuring comfort and personal dignity at all times, whilst the patient’s needs and those of their carers are met with friendship and understanding. Patients and families may be free to attain a degree of mental and spiritual preparation for death that is satisfactory to them.

The recovery from Covid continues to see our traditional methods of fundraising significantly impacted and we continue to be challenged by the cost of living crisis. It seems that the challenge of increasing demand and decreasing income will be with us for some time. The last two years have also brought about significant changes to the hospice sector, as have the new commissioning structures that support our statutory income.

We need to raise £3.35M this year to continue to provide the excellent care and support we give to our patients, their families and carers. The Hospice receives 20% NHS contribution to its cost of delivering care and support to the population of Tameside & Glossop, much lower than national average of 31% (HospiceUK Accounts Report 2022) and compared to other Hospices operating in Greater Manchester region. However, we continue to lobby with our Greater Manchester Collaborative partners for a fairer and more equitable funding model through our local Integrated Care Boards and though our local MPs.

Page 3

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

Forecasting a deficit budget again for the coming year and beyond which will impact on our reserves led to a proposal to Board by the Senior Management Team to invest in the Income Generation and Marketing Team. The investment will put us in a better position to work towards reshaping our fundraising events, corporate support, community engagement, all together with a focus on new ways of increasing our income.

CHARITABLE PURPOSE

DELIVERING PUBLIC BENEFIT

Willow Wood Hospice is an independent charity that provides, free of charge, palliative and end of life care to patients with life limiting illnesses with the aim to help each individual attain the best quality of life (regardless of race, colour or religion) by providing the highest standard of holistic care in a warm, friendly environment. The care offered also extends to patient families, carers and close friends during illness and continuing after bereavement. Willow Wood Hospice is regulated by the Care Quality Commission (CQC), the independent regulator of health and social care in England.

A worthwhile indication of public benefit activities can be seen through the following review of our achievements and performance. There is also further evidence by the response we receive from the community of Tameside and Glossop that we serve. In the 24 years since the Hospice opened its doors, we have become established as a valuable and important part of the community and we receive hundreds of comments and letters of thanks. We embrace feedback in any way and we continually use this information to improve quality in all areas of the service we provide.

We continue to improve and grow through continually assessing the needs of our community and working proactively in ensuring that our services are in-line with both community and government recommendations. Working closely with other local service providers we undertake projects that not only help us provide the best end of life care for patients and their families but that help reduce the burden on the NHS.

Hospices throughout the UK are already leading a range of initiatives that seek, to either prevent avoidable admission to hospital for people approaching the end of life, or facilitate the appropriate and timely transfer of hospital patients who have no clinical need or wish to be in a hospital bed at the end of life.

We have referred to the guidance contained in the Charity Commission’s general guidance on public benefit when reviewing our aims and objectives and in planning our future activities.

OBJECTIVES AND ACTIVITIES (Business Plan under review for 2024)

Strategic Objectives:

  1. Continue to be the main provider of Hospice care, support and education in palliative care throughout Tameside and Glossop.

  2. Promote and widen the services that we offer from Willow Wood Hospice, collaboratively working with other stakeholders as Tameside and Glossop undergoes transformation in line with patient and carer needs.

  3. Raise awareness of Willow Wood Hospice within the Tameside and Glossop communities and within the wider Greater Manchester networks.

  4. Assess and increase the retail portfolio to ensure the continued growth of income from retail activities (carried out via our Subsidiary).

  5. Increase fundraising campaigns to ensure the generation of sufficient income to match the future demands of our expanding services.

  6. Maintain a robust finance, investment and expenditure process.

  7. Attract, develop, retain, support and reward our paid staff and volunteers to ensure a workforce fit to deliver hospice goals.

Page 4

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

Activities for Patient Care and Services

Willow Wood Hospice provides services free of charge to adults with life Limiting illnesses within the Tameside & Glossop region. Our facilities are available to all groups within the communities we serve and the organisation continues to focus on continued improvement of our services.

ACHIEVEMENTS AND PERFORMANCE 2022/2023

In-Patient Unit (IPU)

Willow Wood Hospice are widely recognised by other healthcare providers and the community we serve. Our teams deliver a range of services and outstanding personalised care and support to our patients, their families and carers. We are continually looking to develop our services in order to enhance our care to the community.

The IPU can accommodation up to 12 patients by way of 10 en-suite bedrooms, 8 single and 2 double. The two double rooms are adaptable and enable larger families to spend quality time together to more spacious accommodation.

The unit is designed to provide tailored care and support to patients and their families who are living with the challenges of a terminal illness. We care for patients with terminal conditions: cancer, motor neurone disease, chronic respiratory or cardiac diagnoses such as heart failure, Parkinson’s disease and end stage dementia. Embracing a compassionate approach, our multidisciplinary team works together to: ensure patients with specialist palliative care needs can maximise their quality of living by providing pain and symptom control, emotional and spiritual support and facilitate a safe and timely patient discharge to home or a continuing care service, as well as providing a supportive environment at the end of life.

Data for 2022/2023 :

167 adult inpatient admissions, 26 discharges, 141 deaths

Average bed occupancy was 88% (bed numbers reduced due to staffing shortages). Average length of stay was 9 days.

Wellbeing at the Hive

Throughout the pandemic, with the exception of the In-Patient Unit, other services in the Hospice changed to non-face to face appointments. This resulted in a complete review of services being undertaken, the outcome of which has resulted in the formation of the Community and Wellbeing Service.

The main aim of The Hive is to provide emotional and psychological support to adults who have a palliative diagnosis. Wellbeing at the Hive offers group based and individual sessions, led by experienced healthcare professionals, designed to empower patients and families to live well with their illness.

All these services available in a welcoming lounge and beautiful gardens. They are designed to enhance wellbeing, improve physical function and offer emotional support. Medical support is available as required.

Patients can be referred through a health care professional or self-refer.

Complementary therapies

Our experienced complementary therapists offer individual therapies including, reflexology, reiki, massage and relaxation. The service is for both day and inpatients with an outpatient’s facility. The benefits include relaxation, balance and a feeling of well-being which can in turn help to optimise the person’s quality of life.

Page 5

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

The Therapy Team

A group of experienced multidisciplinary healthcare professionals including physiotherapist, occupational therapist, whose role is to help people living with a life-limiting illness to enhance their quality of life while they manage their illness at the Hospice or in a patient’s own home.

Working closely with the other professionals involved in our patients’ care and refer on to other services if necessary. The team are able to support with planning for future care needs and having discussions around a person’s wishes. The team aim to help manage symptoms by maintaining independence, working towards personal goals to help improve quality of life and providing rehabilitation, education and advice.

Data for 2022/2023 :

162 New referrals, 121 added to caseload, 279 number of home visits

Dementia Team

Willow Wood Dementia Care service reflects our commitment to supporting patients living with advanced dementia, and their families, primarily during the last 12 months of their life. Working with a range of medical professionals the they are able to identify the needs of both patient and carer to provide a holistic approach to care. As well as the Hospice the Dementia service reaches out into our community, offering services directly into homes, care homes and nursing homes engaging with patients in their familiar environment.

Small therapy group sessions are run for people caring for someone living with dementia. Hosted by the Family Support and Bereavement and Dementia Teams at Willow Wood Hospice, the Dementia Carers Support Group meets once a week for eight weeks and the two-hour-long sessions are aimed at partners of people living with dementia. Joining the group gives carers the opportunity to talk about experiences, to learn from each other and share coping strategies, all in a safe environment.

Data for 2022/2023:

85 New referrals to service, 433 Follow up assessments, 499 Home visits,

24 Café Groups

Family Support and Bereavement Services

Our dedicated team is committed to providing comprehensive care that extends far beyond the patient and their illness, encompassing emotional, psychological and spiritual support for the entire family unit.

The Family Support team understand that support should be diverse and inclusive and cover a range of topics. Working together with the wider hospice teams, they strive to provide every patient and family who asks for help with comprehensive and holistic support.

Data for 2022/2023:

134 Adult Referrals: 96 individual adults assessed for the bereavement services.

12 individual children and young adults (3-18 years) accessed the bereavement services Total Counselling Sessions (following assessment) 553

Total number of support groups held 22

Page 6

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

QUALITY AND GOVERNANCE

Trustees and Senior Management recognise the importance of committing to ensuring the delivery of highquality clinical care and promoting patient safety within the Hospice. The investment in a new role of Quality, Governance and Compliance Lead in this financial year will ensure the Hospice commits to a Quality improvement Culture and adherence to statutory regulation Culture as well providing advice on and developing the hospice’s compliance with CQC regulations in relation to legislation and best practice, ensuring that high standards are maintained. This role feeds into our Clinical Governance Committee.

Our Clinical Governance Committee is a subcommittee of the Board of Trustees and is chaired by one of our trustees. The aim of the Clinical Governance Committee is to provide assurance to the Board of Trustees that services are safe, effective, well led, responsive and caring. Driving Clinical Strategy and patient’s safety, alongside the sustainability, accessibility and regulated requirement of Clinical Services. The committees discuss, reviews and challenges the operational delivery of services and provides direction and governance assurance.

Working closely with and as a member of the Clinical Governance Committee the Director of Clinical Services and the Medical Director chair and attend two operational committees that feed into the Clinical Governance committee. The Multi Professional Clinical Leadership Meeting and the Clinical Quality and Standards Meeting.

These meetings ensure quality and safety is managed and standards met. Reporting into the group, members discuss areas including, incident and risk, monitoring and audit, medicines management, infection control, falls and pressure area care, compliments and complaints and drive actions to continuously learn and enhance the patient/carer and staff experience.

EDUCATION

In 2023 the Hospice employed a clinical educator to develop our education packages and learning programmes to staff to improve quality and help make sure that those who are cared for at the end of life by Health and Social Care professionals have the right skills, expertise and confidence. Whilst staff are also encouraged to attend appropriate developmental learning in line with their appraisal and PDP needs, such as management and leadership courses.

Our training package includes E-learning for mandatory training for all our Clinical and non-clinical staff and is managed to ensure statutory compliance.

Through formal agreement with external leaning institutes such as local universities, Willow Wood provides a learning opportunity, through mentoring and training to student nurses, medical students, student occupational therapists, physiotherapists, student counsellors and doctors. Qualified nurses undertake further training and development in areas relevant to their job and role.

STAFFING

The Hospice employs a diverse and immensely skilled workforce that we need to retain and support through development and commitment to them. To enable us to recruit into Clinical roles at the Hospice our pay structure mirrors that of the NHS. All other staff are paid in line with the industry average pay. A remuneration committee meets to discuss the annual pay awards and makes recommendations into the Finance Committee.

Bi-annual staff surveys are undertaken with by external company ‘Birdsong’. It allows us to gather insight and monitor the outcomes from the results of what is important to our employees, measure their engagement, allow them to feel their opinions are valued and identify any early warning signs that issues may arise from. This will also be benchmarked with industry-specific data.

Page 7

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

INCOME GENERATION

With only approximately 20% of our funding coming from the NHS, in order to deliver our charitable activities and ensure we can continue to provide our services free of charge, we must be able to generate sufficient and sustainable income through our fundraising.

The Hospice is grateful for the support of everyone who raise funds on our behalf. Trustees have the ultimately responsibility for our income generation and fundraising activities and so review and approve the strategy budgets each year.

Fundraising

Fundraising was affected greatly by the pandemic and a review of this has been paramount to the future of Hospice income. Nationally, there have been significant changes to the way in which fundraising takes place. A complete review of the fundraising structure and events has been supported by Trustees and Senior Managers.

Mass participation events are poorly attended/supported and we are looking towards corporate support, challenge events, public external events, grants, legacy fundraising, online donation platforms, campaigns and in-memory giving to generate income.

Retail

Willow Wood Hospice is a well-known and highly respected charity and our retail outlets receive large volumes of donations from the public, our local community and beyond. Having retail outlets in our communities promotes and raises awareness of the Hospice and we are always looking to expand on our portfolio.

The Hospice owns a distribution warehouse which operates as a storage facility to ease the burden on the retail outlets, it also houses our substantial internet-based sales operation via eBay and other online portals. A large ground floor retail sales area is now in operation allowing us the opportunity to increase income by offering regular clearance sales. There is also a sorting area for goods and a testing area for electrical items, which are then distributed to individual shops. Another benefit is we are able to store and distribute our selection of seasonal merchandise from here as well as offering storage space for the rest of the organisation.

Lottery

Our Hospice Lottery has seen the impact of the economic crisis with many members cancelling subscriptions. The total number of players fluctuates around 10,000 members. A canvasing company is contracted to undertake recruitment of members at Hospice events. We have also seen a decline in income from the two annual raffle draws.

Volunteers

The largest workforce throughout Willow Wood is our dedicated volunteers who play a vital role in the dayto-day operations of the Hospice work including its lottery and retail operations. It is recognised that the partnership we have with volunteers is vital to the success of the Hospice and without whom we would not function.

We have over 500 active volunteers saving the Hospice over £1M per year in salaries. As with our staff, volunteers have an equally diverse range of skills. Trustees are committed in ensuring that those skills are utilised to the benefit of the Hospice and to the individual.

Our last bi-annual volunteer survey was in 2022 to establish areas for improvement in the Hospice’s management, support and dedication to our volunteers. The Volunteer survey will be repeated in 2023/24.

Page 8

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

FINANCIAL REVIEW

The accounts for the year have been prepared in accordance with the Statement of Recommended Practice – ‘Accounting and Reporting by Charities’ SORP 2019 and complies with all statutory requirements and the governing document of the Hospice. The company meets the definition of a medium sized company and so we have adopted FRS 102 when preparing the accounts.

The Statement of Financial Activities (SOFA) is on page 18 of these financial statements. The Group has made an Operating Deficit in the year (before unrealised gains/losses on Investments) of (£493,496) (2022 Surplus of £365,710).

After adjusting for Unrealised gains/losses on Investments, the Deficit for the year was (£565,512), (2022 Surplus £214,314). In addition to the Unrealised losses the Investment Income in the Year (Note 4.) is also down with Realised Losses on the year of (£9,053) (in 2022 realised Profits of £70,766).

The overall level of Income for the year is down on last year with large reductions in Grants (covid grant from NHS England Grant Income distributed via Hospice UK was still being paid in the year to 30 April 2022), legacies (by over £400,000) and donations from Individuals and Trusts. The income within the Trading Company WWHP are also down and the comparative period contains income from a covid insurance claim of £192,736 other than which the income of the two years is very similar. Against these reductions the hospice saw increases in Gift aid shop sales (and related Gift Aid claims) and Company donations.

During this financial year, we have received an increase in the funding from the Integrated care Boards for Greater Manchester and for Derby and Derbyshire (the two funding Authorities that took over from Tameside and Glossop Clinical Commissioning Group (CCG)) for the year to 30 April 2023 we received £643,422 (2022: £612,077). This ICB Grant is the only regular public funding received by the Hospice towards its medical and running costs (we receive a separate Grant for a proportion of our Dementia service) and this now represents 22.42% (2022: 21.56%) of Hospice Expenditure. The percentage of our costs cover by the grant has gone up slightly this year due both to the small increase in the grant and to the reduction in fundraising costs during the year with leading to a modest overall increase in Hospice costs in the year of only £30,000.

The grant income together with the net income (Deed of Covenant) from our Trading Subsidiary, WWHP, this financial year accounts for 37.28% (2022: 43.10%) of the Hospice and Fundraising Expenditure. The decrease is mainly due to the reduction this year in the Deed of Covenant transfer from WWHP due to the Covid insurance claim in the previous year not reoccurring in 2023.

Total expenditure during the financial year was £2,869,382 (2022: £2,838,695) including restricted expenditure. This small increase in the year is due in several areas, increased Salary (apart from in the Fundraising department due to personnel changes) and operating expenditure areas such as Catering supplies, Medical supplies, Repairs, Website costs, Travel & minibus costs, Heat & Light costs and another increase in Insurance costs. There were a couple of areas of reduced costs during the year, Fundraising Staff Costs (although department costs where higher) and Rental property expenditure. Overall the increase of just over £30,000 is a 1% increase. Against this total income in down by over 25.5%.

Page 9

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

RESERVES POLICY

As an organisation, we are aware that as more people live longer it is likely they will experience multiple complex health needs and that there will be a significant and steady increase in the growth in demand for both palliative and end of life care. Willow Wood Hospice has an essential role to play in helping to meet this demand and we need to ensure that we have the resources in place to facilitate this.

With our high dependency on voluntary donations and legacies, the Trustees consider it essential to have reserves. The aim is to hold at least twelve months running costs in General Unrestricted Reserves. At the balance sheet date this goal has been met in respect to Unrestricted Funds as compared to Unrestricted Expenditure.

However, we should differentiate between Free Reserves and Total General Reserves. General Unrestricted funds at the Balance Sheet date were £3,696,108 (2022: £4,150,731) or 15.8 months (2022: 17.8 months) of Current Year Expenditure (excluding Trading and Lottery expenditure). This decrease has been brought about due to the deficit during the year as expenditure is virtually unchanged as stated in the Financial Review. If we look at Cash and other liquid assets, (Free Reserves), as distinct to total Unrestricted Reserves which include Fixed Assets and Investment properties, these stood at the Balance Sheet date at £2,864,358 (2022: £3,358,961). Of this amount £961,381 (2022: £953,188) have already been designated by the Trustees leaving a balance of £1,902,977 (2021: £2,405,773). These amounts represent 8.16 months (2022: 10.31 months) of Hospice Expenditure (excluding Trading and Lottery expenditure). In addition to the General Reserve an Asset Replacement Reserve is maintained as detailed in note 20 and a schedule of work to the Hospice is currently being assessed and these reserves are being reviewed in the current year in light of this.

As stated above Tameside & Glossop Hospice draws the bulk of its income from the public with only 27.10% (2022: 19.1%) of company General Income coming by way of the annual ICB (previously CCG) grant. This is distorted by the large reduction in income in the year ended 30 April 2023 and the more accurate presentation of percentage is that against expenditure set out in the Financial Review. The uncertainty attached to the various income streams, particularly in terms of legacies, donations and fundraising events, necessitates that we hold substantial reserves. In light of the current turbulent economic situation brought about by the uncertainties and cost of living crisis in the aftermath of Covid 19, the war in Ukraine, rising Electricity and Gas prices, increased interest rates and the impact on people’s disposable income, future income for the Hospice remains uncertain. The medium to long term impact on Income (and ultimately reserves) must await events outside our control in respect the impact that any Climate Change restriction and the ongoing economic uncertainties may have on the financial situation of the country and Hospice.

ASSET REPLACEMENT RESERVE

The 2011 asset replacement provision totalled £437,001. Following a review of the basis of the provision after the completion of the new Hospice wing and refurbishment of the existing building, the total provision did not materially differ to this amount at the time. The Trustees decided therefore that no major adjustments were necessary. Following the replacement of many of our assets, the provision has been enhanced this year by a further £5,000 and at the yearend stood at £502,000. The current year movement on the provision is included within the transfer between funds in note 20.

Page 10

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

INVESTMENT POLICY

The investment policy is reviewed periodically through the Investment/Finance sub-committee and any amendments would be submitted to the Board for approval. It is the charities policy to specifically exclude investing directly in tobacco manufacturing companies and any decisions regarding investment are undertaken after taking appropriate advice from professional advisers. No changes were made to the Policy during the Financial Year.

This year we have continued with our policy of concentrating any new investments in Fixed Interest Deposits with major financial institutions due to continued market uncertainties. However, Willow Wood continues to invest a proportion of its funds in Equities managed externally by professional fund managers. No new money was invested in the Equity portfolio during the year however all dividends and interest received on the portfolio and any Gains on disposals are used to settle Management fees and the balance is reinvested in new Equity investments. The book cost of investments as at the yearend was £1,743,840 (2022: £1,732,081). Compared with this the market value at the yearend date stood at £1,835,522 (2022: £1,916,942). The latest Valuation provided (and reconciled) for the Investment/Finance sub-committee was £1,800,646 at the 31 October 2023 (£1,754,713 at 31 October 2022).

FUTURE PLANS

A new strategic business plan is being developed for 2024 which will form the basis of future operations. However, during the interim period, the current objectives will continue to be monitored by the Trustees and Senior Management team.

  1. Continue to be the main provider of specialist care services in Tameside and Glossop: by constantly monitoring our services, seeking and acting on feedback and by advising, supporting and working with other healthcare providers. Share our expertise and learn with other healthcare providers and the wider community to ensure our people have the necessary knowledge and skills to care for patients with life limiting illnesses.

  2. Promote and widen the services that we offer from Willow Wood Hospice working collaboratively with other stakeholders: identify and expand our services in line with both patient and carer needs, assessing the feasibility of Hospice 7-day admissions. Review the accessibility of our specialist services, including BME, LGBT and minority groups.

  3. Continue to Raise awareness of Willow Wood Hospice within the Tameside and Glossop communities and within the wider Greater Manchester Networks: Keep ahead of competitors by evaluating the Hospice brand, including the logo, standardizing branding and ensuring that the image of the Hospice is ‘up to date’ and reflects what our modern hospice advocates. Promote the services of Willow Wood within the community and the wider Greater Manchester networks.

  4. Assess and increase the retail portfolio to ensure the continued growth of income from retail activities: Continually research potential properties in our community in order to develop and grow our retail activity, including the generation of further ‘department’ stores and coffee shops. Keep ahead of competition and explore diversification of all our retail division creating a wider range of income initiatives

Page 11

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

  1. Develop and Refresh fundraising campaigns to ensure the generation of sufficient income to match future demands on our expanding services: Explore and develop new opportunities for potential income generation from Hospice activities. Continue to assess and maximize usage of space to generate income. Seek opportunities to introduce larger events with the potential to raise greater income through corporate growth. Strengthen and grow corporate supporters and support community fundraising activities. Maximise and review ecommerce activity. Develop public relations and communication strategy in line with the changing dynamics.

  2. Maintain a robust finance, investment and expenditure process: Develop a robust financial reporting system that will ensure the Hospice is ready for future tendering processes. Produce realistic budgets for all departments. Examine all sources of income increasing grant applications as a way of raising funds and analyse expenditure determining where savings can be made.

  3. Attract, develop, retain, support and reward our paid staff and volunteers to ensure a workforce fit to deliver Hospice goals: monitoring staffing levels and structure in line with changing needs and development. Develop a robust staff support system to ensure resilience of staff. Be consistent and effective with the support and development systems for all our people. Ensure Hospice values are reflected in our people process, carry out staff/volunteer satisfaction surveys then act on the relevant elements of the results to ensure staff feel supported and valued.

Page 12

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

STRUCTURE, GOVERNANCE & MANAGEMENT

GOVERNING DOCUMENT

The organisation is a charitable company limited by guarantee, incorporated on 16 September 1993, operating as Willow Wood Hospice. The Company was formed under a Memorandum of Association, which established the objects and powers of the charitable company and is governed under its Articles of Association.

The Company operates a subsidiary company trading known as Willow Wood Hospice Promotions Limited.

TRUSTEE COUNCIL OF MANAGEMENT

Members of the Council of Management, who are directors for the purpose of company law and Trustees for the purpose of charity law, who served during the year and up to the date of this report are shown on page 2. This report lists the Charity Trustees at the balance sheet date and those who had held office during the year; they are all members of the Council. The Company is a company limited by Guarantee with up to 30 members following a change at the AGM of November 2019. The Trustees are elected by the members at the Annual General Meeting to serve a term of three years. One third of the Trustees retire annually but may offer themselves for re-election by the members.

TRUSTEE RECRUITMENT, INDUCTION AND TRAINING

The board endeavours to ensure the make-up of its membership reflects the needs of the Hospice and the community it serves in providing a mix of professional skills necessary for the day-to-day and long term running of the Charity. The skills of our current panel of Trustees include clinicians, legal, architectural, human resourcesemployment Law, health and safety, communications and general professional management.

The organisational structure means the Board of Trustees is responsible for the governance and strategic direction of Willow Wood. The day to day running of the Hospice is delegated to the Chief Executive and Senior Management within pre-defined levels of authority. The Chair and Vice Chair work with the Chief Executive and senior management team and Trustees are on hand with their skills.

Board vacancies are identified through a skills audit by the Chair and board, a role description is formulated and the role is advertised in local media/social media. Newly selected and proposed Trustees are invited to interview and if selected, appointed on a 6-month probationary period. New Trustees are provided with an induction pack, which includes: role description, Hospice Code of Conduct, business plan, annual accounts, Memorandum of Articles, Annual Accounts and published guides on being a Hospice Trustee. Members of the council are expected to achieve 70% attendance in a financial year through either board or sub-committees.

In accordance with our general practice, Board meetings are held once every 12 weeks, the Chief Executive and members of the Senior Management team, attend these meetings. Individual reports from management ensuring all aspects of running the operations are covered. Trustees and Senior Management also set and agree the Hospice Strategic Plan.

In between Board meetings each trustee is allocated a seat/s at strategic sub-meetings which have specific terms of reference and functions including: Finance & Income, Strategic HR/Volunteer, health & safety, clinical governance, clinical strategy, workforce planning and employee engagement forum, all of which encourage collaborative working amongst teams and ensures that all Hospice departments are working together as a wellinformed unit. Each sub group is chaired by a trustee who has experience in that field. Working with the Chief Executive, Senior Managers and hospice staff, the purpose of the committee is for the Trustee to report back to board, make proposals and recommendations which in turn allows the monitoring and progress of objectives.

Willow Wood is a team-based operation. All personnel at Willow Wood must identify with our values, purpose and vision: to continue to be a leader in Hospice care, providing excellence in quality care to the people of Tameside and Glossop.

Page 13

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2023

RISK MANAGEMENT

The major risks to which the Charity is exposed as identified by the Trustees have been reviewed and strategies have been established to mitigate these risks. This involves identifying the types of risk the charity faces, prioritising them in terms of potential impact and likelihood of occurrence and identifying means of eliminating or mitigating the risks as appropriate. Risks are under continuous review and evaluation.

RESPONSIBILITIES OF THE COUNCIL OF MANAGEMENT

The Trustees, (who are also the directors of Tameside and Glossop Hospice Ltd for the purposes of company law) are responsible for preparing the Trustees’ Annual Report and the financial statements. These are prepared in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice) including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland”.

Company law requires the Trustees to prepare financial statements for each financial year that give a true and fair view of the state of affairs of the charitable company as at the end of the financial year and of the surplus or deficit of the company for that period. In preparing those financial statements, the Trustees are required to:

The Trustees are responsible for maintaining proper accounting records that disclose with reasonable accuracy at any time the financial position of the company and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT OF DISCLOSURE TO AUDITORS

In accordance with company law, as the company’s directors, we certify that:

Report of the trustees, incorporating a strategic report, approved by order of the board of trustees, as the company directors, on 19 January 2024 and signed on the board's behalf by:

…………………………………………………………………. John H. Maltby LLB (Company Director/Trustee)

Page 14

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF TAMESIDE & GLOSSOP HOSPICE LIMITED

Opinion

We have audited the financial statements of Tameside & Glossop Hospice Limited (the 'parent charitable company') and its subsidiary (‘the group’) for the year ended 30 April 2023 which comprise the consolidated Statement of Financial Activities, the consolidated Balance Sheet, the Company Balance Sheet, the consolidated Cash Flow Statement and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the Annual Report, other than the financial statements and our Report of the Independent Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Page 15

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF TAMESIDE & GLOSSOP HOSPICE LIMITED

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Trustees.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the Statement of Trustees' Responsibilities, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the group and charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Page 16

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF TAMESIDE & GLOSSOP HOSPICE LIMITED

Our responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Independent Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Enquiries were made of the Trustees and management with a view to identifying those laws and regulations that could be expected to have a material impact on the financial statements.

We obtained an understanding of the legal and regulatory framework that the company operates in, and the principal risks of non-compliance with laws and regulations which we identified as being significant to the company related to UK Financial Reporting Standards, Company Law, Charity Law, UK Tax Legislation and Health & Safety regulations. We considered the extent to which the non-compliance with these regulations would have an impact on the accounts.

The audit procedures we undertook in response to the potential risks relating to irregularities (which include fraud and non-compliance with laws and regulations) included, but not limited to:

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Independent Auditors.

Use of our report

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members as a body, for our audit work, for this report, or for the opinions we have formed.

David Evans FCA (Senior Statutory Auditor) for and on behalf of Moss & Williamson Limited Chartered Accountants Statutory Auditor Booth Street Chambers Ashton-under-Lyne Lancashire OL6 7LQ

Date: 19 January 2024

Page 17

TAMESIDE & GLOSSOP HOSPICE LIMITED

CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING AN INCOME AND EXPENDITURE ACCOUNT) for the Year Ended 30 April 2023

Notes
INCOME AND ENDOWMENTS FROM
Donations and legacies
2
Other trading activities
3
Investment income
4
Other income
Total
EXPENDITURE ON
Raising funds
Raising donations and legacies
5
Charitable activities
6
Hospice
Fundraising
Governance
Lottery
Trading expenses
Total
Net gains/(losses) on investments
NET INCOME/(EXPENDITURE)
RECONCILIATION OF FUNDS
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD		 Unrestricted
funds
£
1,504,359
1,588,689
145,552
41,015
3,279,615
178,989
178,989
2,459,537
52,159
40,818
184,373
790,128
3,706,004
(72,016)
(498,405)
6,651,288
6,152,883		 Restricted
fund
£
74,267
-
-
-
74,267
-
-
141,374
-
-
-
-
141,374
-
(67,107)
256,584
189,477		 2023
Total
funds
£
1,578,626
1,588,689
145,552
41,015
3,353,882
178,989
178,989
2,600,911
52,159
40,818
184,373
790,128
3,847,378
(72,016)
(565,512)
6,907,872
6,342,360		 2022
Total
funds
£
2,211,023
1,581,391
173,495
216,595
4,182,504
269,538
269,538
2,487,752
46,068
35,337
199,004
779,095
3,816,794
(151,396)
214,314
6,693,558
6,907,872

The notes form part of these financial statements

Page 18

TAMESIDE & GLOSSOP HOSPICE LIMITED

CONSOLIDATED BALANCE SHEET 30 April 2023

Notes
FIXED ASSETS
Tangible assets
13
Investments
Investments
14
Investment property
15
CURRENT ASSETS
Stocks
16
Debtors
17
Cash at bank and in hand
CREDITORS
Amounts falling due within one year
18
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT
LIABILITIES
NET ASSETS
FUNDS
20
Unrestricted funds:
General fund
Designated
Restricted funds:
Restricted
TOTAL FUNDS		 Unrestricted
Restricted
funds
fund

£
£
2,575,229
18,158
2,656,500
171,319
215,000
-
5,446,729
189,477
11,518
-
481,959
-
635,646
-
1,129,123
-
(422,969)
-
706,154
-
6,152,883
189,477
6,152,883
189,477		 2023

Total
funds
£
2,593,387
2,827,819
215,000
5,636,206
11,518
481,959
635,646
1,129,123
(422,969)
706,154
6,342,360
6,342,360
3,696,684
2,456,199
6,152,883
189,477
6,342,360		 2022
Total
funds
£
2,623,384
3,339,051
215,000
6,177,435
16,955
533,001
576,701
1,126,657
(396,220)
730,437
6,907,872
6,907,872
4,151,307
2,499,981
6,651,288
256,584
6,907,872

The financial statements were approved by the Board of Trustees and authorised for issue on 19 January 2024 and were signed on its behalf by:

............................................. John H. Maltby LLB (Trustee)

The notes form part of these financial statements

Page 19

TAMESIDE & GLOSSOP HOSPICE LIMITED

COMPANY BALANCE SHEET 30 April 2023

Notes
FIXED ASSETS
Tangible assets
13
Investments
Investments
14
Investment property
15
CURRENT ASSETS
Stocks
16
Debtors
17
Cash at bank and in hand
CREDITORS
Amounts falling due within one year
18
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT
LIABILITIES
NET ASSETS
FUNDS
20
Unrestricted funds:
General fund
Designated
Restricted funds:
Restricted
TOTAL FUNDS		 Unrestricted
Restricted
funds
fund

£
£
2,536,533
18,158
2,656,510
171,319
215,000
-
5,408,043
189,477
11,518
-
1,014,521
-
36,529
-
1,062,568
-
(318,304)
-
744,264
-
6,152,307
189,477
6,152,307
189,477		 2023

Total
funds
£
2,554,691
2,827,829
215,000
5,597,520
11,518
1,014,521
36,529
1,062,568
(318,304)
744,264
6,341,784
6,341,784
3,696,108
2,456,199
6,152,307
189,477
**6,341,784 **		 2022
Total
funds
£
2,613,324
3,339,061
215,000
6,167,385
16,955
981,910
19,900
1,018,765
(278,854)
739,911
6,907,296
6,907,296
4,150,731
2,499,981
6,650,712
256,584
6,907,296

The financial statements were approved by the Board of Trustees and authorised for issue on 19 January 2024 and were signed on its behalf by:

............................................. John H. Maltby LLB (Trustee)

The notes form part of these financial statements

Page 20

TAMESIDE & GLOSSOP HOSPICE LIMITED

CONSOLIDATED CASH FLOW STATEMENT for the Year Ended 30 April 2023

Notes
Cash flows from operating activities
Cash generated from operations
1
Net cash (used in)/provided by operating activities
Cash flows from investing activities
Purchase of tangible fixed assets
Purchase of fixed asset investments
Sale of fixed asset investments
Dividends received
Net cash provided by/(used in) investing activities
Change in cash and cash equivalents
in the reporting period
Cash and cash equivalents at the
beginning of the reporting period
Cash and cash equivalents at the end
of the reporting period		 2023
£
(345,077)
(345,077)
(66,814)
(105,665)
544,881
31,620
404,022
58,945
576,701
635,646		 2022
£
312,114
312,114
(24,950)
(345,612)
147,619
104,777
(118,166)
193,948
382,753
576,701

The notes form part of these financial statements

Page 21

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT for the Year Ended 30 April 2023

1. RECONCILIATION OF NET (EXPENDITURE)/INCOME TO NET CASH FLOW FROM RECONCILIATION OF NET (EXPENDITURE)/INCOME TO NET CASH FLOW FROM OPERATING
ACTIVITIES
2023 2022
£ £
Net (expenditure)/income for the reporting period (as per the
Statement of Financial Activities) (565,512) 214,314
Adjustments for:
Depreciation charges 96,811 104,144
Losses on investments 72,016 151,396
Dividends received (31,620) (104,777)
Decrease in stocks 5,437 4,418
Decrease/(increase) in debtors 51,042 (86,444)
Increase in creditors 26,749 29,063
Net cash (used in)/provided by operations (345,077) 312,114
2. ANALYSIS OF CHANGES IN NET FUNDS
At 1.5.22 Cash flow At 30.4.23
£ £ £
Net cash
Cash at bank and in hand **576,701 ** 58,945 635,646
**576,701 ** 58,945 635,646
Total **576,701 ** 58,945 635,646

The notes form part of these financial statements

Page 22

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS for the Year Ended 30 April 2023

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value, as modified by the revaluation of certain assets.

The presentation currency of the financial statements is the pound Sterling (£).

Group financial statements

The consolidated financial statements incorporate the financial statements of the company and entities (including special purpose entities) controlled by the group (its subsidiaries). Control is achieved where the group has the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities.

The results of subsidiaries acquired or disposed of during the year are included in total comprehensive income from the effective date of acquisition and up to the effective date of disposal, as appropriate using accounting policies consistent with those of the parent.

All intra-group transactions, balances, income and expenses are eliminated in full on consolidation. Investments in subsidiaries are accounted for at cost less impairment in the individual financial statements.

Preparation of the accounts ongoing concern basis

The Trustees consider there are no material uncertainties about the Group’s ability to continue as a going concern.

In the application of the Charity’s accounting policies the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimated and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimates are recognised, in the period in which the estimate is revised where the revision affect only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

The Trustees do not consider that there are any sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities within the next accounting period.

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Page 23

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS for the Year Ended 30 April 2023

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Allocation and apportionment of costs

Fund-raising costs are those incurred in seeking voluntary contributions including marketing and advertising but do not include the costs of disseminating information in support of charitable activities.

Governance costs are those incurred in connection with governance of the charity and are associated with constitutional and statutory requirements and strategic non day-to-day management of the charity's activities.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Freehold property - 2% on cost Long leasehold - 2% on cost Plant and machinery - 20% on cost Computer equipment - 33% on cost

Investment property

Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in the Statement of Financial Activities.

Stocks

Bought in stocks are valued at the lower of cost or net realisable value after making due allowance for obsolete or slow moving items. Unsold donated items are not included in closing stock because of the uncertainty and impracticality of valuation.

Taxation

The charity is exempt from corporation tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Page 24

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

1. ACCOUNTING POLICIES - continued

Fund accounting

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Designated Funds are unrestricted funds with the specific purpose of funding the building and development of Willow Wood Hospice and includes £100,000 as a Support Grant (enhanced by interest generated on the funds specifically invested for these purposes) and £497,000 as an Asset Replacement Provision. In addition, several years ago the Hospice received two grants from the PCT totalling £936,118 which the Trustees allocated for the building extension and extensive Hospice refurbishment programme that was undertaken. The net balance of these grants continue to be held by the Trustees against future refurbishment costs and continue to be enhanced by interest generated on funds invested for this purpose. Two further grants of £60,000 were received during 2012 from the PCT and the Trustees have designated these for future Hospice development. Again, these are enhanced by interest generated on the funds invested for this purpose. At the balance sheet date, the Designated Funds invested for future Hospice development stands at £961,381 (2022: £953,188). The remainder of the Designated funds have already been spent by the Trustees and are within the Accounts as Long Leasehold Property £1,494,818 (2022 - £1,546,793).

Pension costs and other post-retirement benefits

For those people for whom pension contributions are made the company pays into the NHS final salary (defined benefit) pension scheme and a separate Stakeholder (money purchase) pension scheme. The company also pays into an auto enrolment pension scheme. Contributions payable to all these schemes are charged to the profit and loss account in the period to which they relate. These contributions are invested separately from the company’s assets.

Voluntary help and gifts in kind

No value has been placed on the help received by Tameside & Glossop Hospice Limited during the year. The charity receives a number of non-cash donations, it is not practicable for these gifts in kind to be recognised and valued when received. Income is accounted for in the accounting period in which the gift is sold. There were no individual gifts of significant value.

2. DONATIONS AND LEGACIES

Grants
Individuals
Companies
99ers Club
Trusts
In Memoriam
Gift aid shop sales
Gift Aid/G.A.Y.E.
Collecting cans
Deed of covenant
Legacies
Death certificates
Members' subscriptions		 2023
£
672,953
54,495
65,098
2,100
46,072
147,613
181,627
82,923
19,264
11,117
285,251
9,613
500
1,578,626		 2022
£
868,206
67,178
45,892
3,394
131,275
156,271
138,673
74,196
17,090
12,313
686,339
9,676
520
2,211,023

Page 25

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

2. DONATIONS AND LEGACIES - continued

Grants received, included in the above, are as follows:

Other grants
3.
OTHER TRADING ACTIVITIES
Shop income
Lottery income
Superdraw income
External Fundraising
Internal Fundraising
Sale of promotional items
Calendars & Christmas cards
Seasonal promotions
Appeal income
Coffee mornings
Light up a Life
Midnight Wander
Hospice ball
Sahara Trek
Butterfly Release
Golf day
Bunny hop
Memory stone
Direct mail campaign
Strictly Come Dancing
4.
INVESTMENT INCOME
Rent received
Interest on Investments
Dividends received
Profit-disposal of investments

Page 26

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

5.
RAISING DONATIONS AND LEGACIES
Staff costs
Fundraising costs
6.
CHARITABLE ACTIVITIES COSTS
Hospice
Fundraising
Governance
Lottery
Trading expenses
7.
DIRECT COSTS OF CHARITABLE ACTIVITIES
Staff costs
Therapy costs & consumables
Support costs
Stationery
Catering supplies
Medical supplies
Training expenses
Laundry & cleaning
Waste disposal
Depreciation
Repairs & maintenance
Rental property expenditure
Sundry equipment
Website costs
Travel & minibus
Criminal record checking
Recruitment
Trading expenses of subsidiary
Lottery prizes
Superdraw prizes
Lottery administration costs		 Direct
Costs (see
note 7)
£
2,124,808
12,119
3,495
184,373
790,128
3,114,923

Page 27

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

8. SUPPORT COSTS

Management
£
Hospice
470,578
Fundraising
36,840
Governance
-
507,418
Support costs, included in the above, are as follows:		 Governance
Finance
costs
£
£
5,525
-
3,200
-
-
37,323
8,725
37,323		 Totals
£
476,103
40,040
37,323
553,466

Management

Salaries, NI & pensions
Rates and water
Insurance
Heat & light
Communications
Postage
Computer support costs
Sundry expenses
Subscription/registration fees
Portfolio management fees
Depreciation of tangible and heritage
assets
Finance
Bank charges		 Hospice
Fundraising
£
£
295,370
22,232
11,424
860
24,758
1,864
33,777
2,542
6,505
490
2,932
484
50,421
4,398
20,239
1,569
3,686
785
15,391
1,159
6,075
457
470,578
36,840
Hospice
Fundraising
£
£
5,525
3,200		 2023
Total
activities
£
317,602
12,284
26,622
36,319
6,995
3,416
54,819
21,808
4,471
16,550
6,532
507,418
2023
Total
activities
£
8,725		 2022
Total
activities
£
278,046
14,319
22,667
30,283
7,026
3,054
51,887
17,272
4,073
17,180
6,986
452,793
2022
Total
activities
£
9,208

Page 28

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

8. SUPPORT COSTS - continued Governance costs

2023
Governance
activities
£
Legal & professional fees
28,613
Audit & Accountancy
8,710
37,323		 2022
Total
£
26,687
8,650
35,337

9. NET INCOME/(EXPENDITURE)

Net income/(expenditure) is stated after charging/(crediting):

Depreciation - owned assets
Auditors remuneration		 2023
£
96,811
8,710		 2022
£
104,144
8,650

10. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 30 April 2023 nor for the year ended 30 April 2022.

Trustees' expenses

There were no trustees' expenses paid for the year ended 30 April 2023 nor for the year ended 30 April 2022.

11. STAFF COSTS

Wages and salaries
Social Security costs
Pension costs		 2023
£
2,495,229
191,217
114,863
2,801,309		 2022
£
2,505,287
204,618
111,658
2,821,563

The average monthly number of employees during the year was as follows:

Employees 2023
**101 **		 2022
99

Page 29

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

11. STAFF COSTS - continued

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:

£70,001 - £80,000
12.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
funds
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
1,826,741
Other trading activities
1,581,391
Investment income
173,495
Other income
216,595
Total
3,798,222
EXPENDITURE ON
Raising funds
Raising donations and legacies
269,538
269,538
Charitable activities
Hospice
2,149,603
Fundraising
46,068
Governance
35,337
Lottery
199,004
Trading expenses
779,095
Total
3,478,645
Net gains/(losses) on investments
(151,396)
NET INCOME
168,181
RECONCILIATION OF FUNDS
Total funds brought forward
6,483,107
TOTAL FUNDS CARRIED FORWARD
6,651,288		 2023
1
Restricted
fund
£
384,282
-
-
-
384,282
-
-
338,149
-
-
-
-
338,149
-
46,133
210,451
256,584		 2022
1
Total
funds
£
2,211,023
1,581,391
173,495
216,595
4,182,504
269,538
269,538
2,487,752
46,068
35,337
199,004
779,095
3,816,794
(151,396)
214,314
6,693,558
6,907,872

Page 30

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

13. TANGIBLE FIXED ASSETS

GROUP

COST
At 1 May 2022
Additions
At 30 April 2023
DEPRECIATION
At 1 May 2022
Charge for year
At 30 April 2023
NET BOOK VALUE
At 30 April 2023
At 30 April 2022
COST
At 1 May 2022
Additions
At 30 April 2023
DEPRECIATION
At 1 May 2022
Charge for year
At 30 April 2023
NET BOOK VALUE
At 30 April 2023
At 30 April 2022		 Plant and
machinery
£
405,111
19,392
424,503
378,562
11,504
390,066
34,437
26,549		 Freehold
property
£
669,557
-
669,557
135,760
13,391
149,151
520,406
533,797
Motor
vehicles
£
63,970
-
63,970
63,970
-
63,970
-
-		 Improvements
Long
to
leasehold
property
£
£
3,204,810
9,364
-
31,695
3,204,810
41,059
1,155,505
468
62,685
2,699
1,218,190
3,167
1,986,620
37,892
2,049,305
8,896
Computer
equipment
Totals
£
£
67,728
4,420,540
15,727
66,814
83,455
4,487,354
62,891
1,797,156
6,532
96,811
69,423
1,893,967
14,032
2,593,387
4,837
2,623,384

Page 31

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

13. TANGIBLE FIXED ASSETS – continued COMPANY

COST
At 1 May 2022
Additions
At 30 April 2023
DEPRECIATION
At 1 May 2022
Charge for year
At 30 April 2023
NET BOOK VALUE
At 30 April 2023
At 30 April 2022
COST
At 1 May 2022
Additions
At 30 April 2023
DEPRECIATION
At 1 May 2022
Charge for year
At 30 April 2023
NET BOOK VALUE
At 30 April 2023
At 30 April 2022		 Freehold
property
£
669,557
-
669,557
135,760
13,391
149,151
520,406
533,797
Motor
vehicles
£
63,970
-
63,970
63,970
-
63,970
-
-		 Long
leasehold
£
3,134,294
-
3,134,294
1,084,989
62,685
1,147,674
1,986,620
2,049,305
Computer
equipment
£
67,728
15,727
83,455
62,891
6,532
69,423
14,032
4,837		 Plant and
machinery
£
366,604
19,392
385,996
341,219
11,144
352,363
33,633
25,385
Totals
£
4,302,153
35,119
4,337,272
1,688,829
93,752
1,782,581
2,554,691
2,613,324

Page 32

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

14. FIXED ASSET INVESTMENTS GROUP

MARKET VALUE
At 1 May 2022
Additions
Disposals
Unrealised gain
At 30 April 2023
NET BOOK VALUE
At 30 April 2023
At 30 April 2022
COMPANY
MARKET VALUE
At 1 May 2022
Additions
Disposals
Revaluations
At 30 April 2023
NET BOOK VALUE
At 30 April 2023
At 30 April 2022		 Shares in
group
undertakings
£
10
-
-
-
10
10
10		 Listed
investments
£
1,916,942
105,665
(114,725)
(72,016)
1,835,866
1,835,866
1,916,942
Listed

investments
£
1,916,942
105,665
(114,725)
(72,016)
1,835,866
1,835,866
1,916,942		 Notice &
Term bank
accounts
£
1,422,109
-
(430,156)
-
991,953
991,953
1,422,109
Notice &
Term bank
accounts
£
1,422,109
-
(430,156)
-
991,953
991,953
1,422,109		 Totals
£
3,339,051
105,665
(544,881)
(72,016)
2,827,819
2,827,819
3,339,051
Totals
£
3,339,061
105,665
(544,881)
(72,016)
2,827,829
2,827,829
3,339,061

There were no investment assets outside the UK.

Cost or valuation at 30 April 2023 is represented by:

Valuation in 2023
Cost		 Shares in
group
Listed
undertakings investments
£
£
-
1,835,866
10
-
10
1,835,866		 Notice &
Term bank

accounts
£
-
991,953
991,953		 Totals
£
1,835,866
991,963
2,827,829

Page 33

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

14. FIXED ASSET INVESTMENTS - continued

The company's investments at the balance sheet date in the share capital of companies include the following:

Willow Wood Hospice Promotions Limited

Registered office: Willow Wood Close Mellor Road, Ashton-under-Lyne, Lancashire Nature of business: Running charity shops and lottery.

%
Class of share:
holding
Ordinary
100
2023
£
Aggregate capital and reserves
586
15.
INVESTMENT PROPERTY
FAIR VALUE
At 1 May 2022
and 30 April 2023
NET BOOK VALUE
At 30 April 2023
At 30 April 2022		 2022
£
586
£
215,000
215,000
215,000

The Investment Properties were acquired as part of two legacies left to the Hospice. Both are Residential Properties and the Trustees made the decision to let the properties out to generate on going funds for the Hospice.

16.
STOCKS
Stocks
Stocks consist of items acquired for medical and fundraising purposes.
17.
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
GROUP
Debtors & prepayments
Other debtors
VAT
COMPANY
Debtors & prepayments
Amounts owed by group undertakings
Other debtors
VAT

Page 34

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

18. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

GROUP

Trade creditors
Social security and other taxes
Other creditors
Grants received in advance
Accruals & deferred income
COMPANY
Trade creditors
Social security and other taxes
Other creditors
Grants received in advance
Accruals & deferred income		 2023
£
71,390
85,719
86,000
117,410
62,450
422,969
2023
£
51,781
85,719
944
117,410
62,450
**318,304 **		 2022
£
70,870
79,759
106,142
112,162
27,287
396,220
2022
£
33,095
79,759
26,551
112,162
27,287
278,854

19. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:

GROUP
Within one year
Between one and five years
In more than five years
COMPANY
Within one year
Between one and five years
In more than five years		 2023
£
-
62,620
137,175
199,795
2023
£
-
31,287
7,500
**38,787 **		 2022
£
5,878
69,886
82,504
158,268
2022
£
2,521
3,470
35,704
41,695

Page 35

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

20. MOVEMENT IN FUNDS

GROUP

Unrestricted funds
General fund
Designated
Restricted funds
Restricted
TOTAL FUNDS		 At 1.5.22
£
4,151,307
2,499,981
6,651,288
256,584
6,907,872		 Net
movement
in funds
£
(449,623)
(48,782)
(498,405)
(67,107)
(565,512)		 Transfers
between
funds
£
(5,000)
5,000
-
-
-		 At
30.4.23
£
3,696,684
2,456,199
6,152,883
189,477
6,342,360

Net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Designated
Restricted funds
Restricted
TOTAL FUNDS		 Incoming
resources
£
3,276,422
3,193
3,279,615
74,267
**3,353,882 **		 Resources
expended
£
(3,654,029)
(51,975)
(3,706,004)
(141,374)
**(3,847,378) **		 Gains and
losses
£
(72,016)
-
(72,016)
-
**(72,016) **		 Movement
in funds
£
(449,623)
(48,782)
(498,405)
(67,107)
(565,512)

Page 36

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

20. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

Unrestricted funds
General fund
Designated
Restricted funds
Restricted
TOTAL FUNDS		 At 1.5.21
£
3,934,001
2,549,106
6,483,107
210,451
6,693,558		 Net
movement
in funds
£
222,306
(54,125)
168,181
46,133
214,314		 Transfers
between
funds
£
(5,000)
5,000
-
-
-		 At
30.4.22
£
4,151,307
2,499,981
6,651,288
256,584
6,907,872

Comparative net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Designated
Restricted funds
Restricted
TOTAL FUNDS		 Incoming
resources
£
3,797,766
456
3,798,222
384,282
4,182,504		 Resources
expended
£
(3,424,064)
(54,581)
(3,478,645)
(338,149)
(3,816,794)		 Gains and
losses
£
(151,396)
-
(151,396)
-
(151,396)		 Movement
in funds
£
222,306
(54,125)
168,181
46,133
214,314

A current year 12 months and prior year 12 months combined position is as follows:

Unrestricted funds
General fund
Designated
Restricted funds
Restricted
TOTAL FUNDS		 At 1.5.21
£
3,934,001
2,549,106
6,483,107
210,451
6,693,558		 Net
movement
in funds
£
(227,317)
(102,907)
(330,224)
(20,974)
(351,198)		 Transfers
between
funds
£
(10,000)
10,000
-
-
-		 At
30.4.23
£
3,696,684
2,456,199
6,152,883
189,477
6,342,360

Page 37

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

20. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Designated
Restricted funds
Restricted
TOTAL FUNDS		 Incoming
resources
£
7,074,188
3,649
7,077,837
458,549
7,536,386		 Resources
expended
£
(7,078,093)
(106,556)
(7,184,649)
(479,523)
(7,664,172)		 Gains and
losses
£
(223,412)
-
(223,412)
-
(223,412)		 Movement
in funds
£
(227,317)
(102,907)
(330,224)
(20,974)
(351,198)

21. EMPLOYEE BENEFIT OBLIGATIONS

The Charity operates two pension schemes for staff and these are outlined below:

National Health Service Superannuation Scheme

The group is an admitted body for the purposes of the National Health Service Superannuation Scheme. Due to the nature of the scheme there are no separately identifiable assets or liabilities which can be identified as relating to the Hospice. Therefore the scheme has been accounted for as a defined contribution scheme.

The amount of contributions recognised in the statement of financial activity as an expense is £93,932 (2022: £89,290).

Stakeholder Pension Scheme

The group supports a Stakeholder Pension Auto-enrolment scheme operated by Standard Life. Employee contributions are collected by the Hospice and matching employer's contributions are passed on to Standard Life. All the assets and liabilities are held by Standard Life and there are no separately identifiable assets or liabilities which can be identified as relating to the Hospice. Therefore the scheme has been accounted for as a defined contribution scheme.

The amount of contributions recognised in the statement of financial activity as an expense is £64,121 (2022: £65,003).

Page 38

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2023

22. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 30 April 2023.

23. INDIVIDUAL STATEMENT OF FINANCIAL ACTIVITY

As permitted by Section 408 of the Companies Act 2006, the Statement of Financial Activity of the parent Charity is not presented as part of these financial statements.

Page 39

TAMESIDE & GLOSSOP HOSPICE LIMITED

DETAILED STATEMENT OF FINANCIAL ACTIVITIES for the Year Ended 30 April 2023

INCOME AND ENDOWMENTS
Donations and legacies
Grants
Individuals
Companies
99ers Club
Trusts
In Memoriam
Gift aid shop sales
Gift Aid/G.A.Y.E.
Collecting cans
Deed of covenant
Legacies
Death certificates
Members' subscriptions
Other trading activities
Shop income
Lottery income
Superdraw income
External Fundraising
Internal Fundraising
Sale of promotional items
Calendars & Christmas cards
Seasonal promotions
Appeal income
Coffee mornings
Light up a Life
Midnight Wander
Hospice ball
Sahara Trek
Butterfly Release
Golf day
Bunny hop
Memory stone
Direct mail campaign
Strictly Come Dancing
Investment income
Rent received
Interest on Investments
Dividends received
Profit-disposal of investments		 2023
£
672,953
54,495
65,098
2,100
46,072
147,613
181,627
82,923
19,264
11,117
285,251
9,613
500
1,578,626
832,157
535,785
36,228
79,166
22,807
7,774
(5,616)
615
3,180
7,491
2,628
6,487
-
5,900
4,262
5,495
17,802
2,877
12,184
11,467
1,588,689
109,648
4,284
40,673
(9,053)
145,552		 2022
£
868,206
67,178
45,892
3,394
131,275
156,271
138,673
74,196
17,090
12,313
686,339
9,676
520
2,211,023
813,921
535,968
42,726
64,781
21,509
6,074
(4,257)
88
3,578
1,340
5,810
27,668
1,908
(6,939)
3,329
3,949
38,473
2,794
6,304
12,367
1,581,391
68,571
147
34,011
70,766
173,495

This page does not form part of the statutory financial statements

Page 40

TAMESIDE & GLOSSOP HOSPICE LIMITED

DETAILED STATEMENT OF FINANCIAL ACTIVITIES for the Year Ended 30 April 2023

Investment income
Other income
Other income
Total incoming resources
EXPENDITURE
Raising donations and legacies
Staff costs
Fundraising costs
Charitable activities
Staff costs
Pensions
Therapy costs & consumables
Support costs
Stationery
Catering supplies
Medical supplies
Training expenses
Laundry & cleaning
Waste disposal
Depreciation
Repairs & maintenance
Rental property expenditure
Sundry equipment
Website costs
Travel & minibus
Criminal record checking
Recruitment
Trading expenses of subsidiary
Lottery prizes
Superdraw prizes
Lottery administration costs
Support costs
Management
Salaries, NI & pensions
Rates and water
Insurance
Heat & light
Communications
Postage
Computer support costs
Carried forward		 2023
£
41,015
3,353,882
157,335
21,654
178,989
1,788,418
-
1,438
55,314
7,247
46,488
28,416
6,222
16,739
7,405
87,220
46,917
6,410
1,654
16,121
13,240
-
7,678
793,623
75,789
5,470
103,114
3,114,923
317,602
12,284
26,622
36,319
6,995
3,416
54,819
458,057		 2022
£
216,595
4,182,504
259,054
10,484
269,538
1,765,982
1
1,265
44,747
6,159
36,021
22,292
3,975
15,855
7,518
87,330
39,414
18,435
1,727
8,630
8,643
1,422
2,403
779,095
75,765
7,500
115,739
3,049,918
278,046
14,319
22,667
30,283
7,026
3,054
51,887
407,282

This page does not form part of the statutory financial statements

Page 41

TAMESIDE & GLOSSOP HOSPICE LIMITED

DETAILED STATEMENT OF FINANCIAL ACTIVITIES for the Year Ended 30 April 2023

Management
Brought forward
Sundry expenses
Subscription/registration fees
Portfolio management fees
Depn of computer equip. etc
Finance
Bank charges
Governance costs
Legal & professional fees
Audit & Accountancy
Total resources expended
Net (expenditure)/income		 2023
£
458,057
21,808
4,471
16,550
6,532
507,418
8,725
28,613
8,710
37,323
3,847,378
**(493,496) **		 2022
£
407,282
17,272
4,073
17,180
6,986
452,793
9,208
26,687
8,650
35,337
3,816,794
365,710

This page does not form part of the statutory financial statements

Page 42